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Caractéristiques des patients, durée de séjour, et amélioration
fonctionnelle pour les troubles du spectre de la schizophrénie:
une étude dans la population des soins des patients hospitalisés
en Ontario de 2005 à 2015

Sheng Chen, PhD1, April Collins, MSW, MSc1, Kelly Anderson, PhD2,3,
Kwame McKenzie, MD1,4, and Sean Kidd, PhD1,4

Abstract
Objectives: Schizophrenia and associated illnesses account for a large proportion of mental illness burden and health care
expenditures, with the majority of expense involving inpatient care. To date, the literature exploring factors associated with
length of stay (LOS) and functional improvement during inpatient care is underdeveloped. In response, this study examined the
association between patient characteristics, LOS, and functional improvement using Ontario Mental Health Reporting System
(OMHRS) data from 2005 to 2015.
Methods: The associations of patient characteristics (including key demographics, psychosocial variables, reasons for
admission, and service use history) and 2 outcome measures (LOS and Global Assessment of Functioning [GAF]) were
analysed with generalised linear mixed modelling (GLMM). From 2005 to 2015, a total of 48,498 episodes for distinct patients
from 18 psychiatric hospitals and 57 general hospitals in Ontario were included.
Results: For psychiatric and general hospitals, mean LOS was 96.6 and 20.5 days, and mean GAF improvement was 14.8 and
16.1, respectively. The majority of associations probed demonstrated a high degree of significance with similar patterns across
general and tertiary facility contexts. Older age and more recent readmission following a psychiatric discharge were associated
with longer LOS and less GAF improvement. Recent experience of adverse life events and substance misuse were associated
with shorter LOS.
Conclusions: While the findings of this exploratory cross-sectional analysis will require further inquiry with respect to
validity and reliability, they suggest that a different service pathway is likely required for individuals with greater psychosocial
challenge and extensive service use histories.
Abrégé
Objectif : La schizophrénie et les maladies apparentées représentent une large proportion du fardeau de la maladie mentale
et des dépenses de soins de santé, la majorité des dépenses impliquant les soins des patients hospitalisés. Jusqu’ici, la littérature
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explorant les facteurs associés à la durée de séjour (DDS) et à l’amélioration fonctionnelle durant l’hospitalisation des
patients est sous-développée. En réponse, cette étude a examiné l’association entre les caractéristiques des patients, la
DDS et l’amélioration fonctionnelle à l’aide des données du Système d’information ontarien sur la santé mentale (SIOSM) de
2005 à 2015.
Méthodes : Les associations entre les caractéristiques des patients (y compris les données démographiques, les variables
psychosociales, les raisons de l’hospitalisation, et les antécédents d’utilisation des services) et 2 mesures des résultats [la DDS
et l’Échelle d’évaluation globale du fonctionnement (GAF)] ont été analysées avec un modèle linéaire généralisé (GLMM). De
2005 à 2015, les données de 48 498 épisodes de patients distincts de 18 hôpitaux psychiatriques et de 57 hôpitaux généraux
d’Ontario ont été incluses.
Résultats : Pour les hôpitaux psychiatriques et généraux, la DDS moyenne était de 96,6 jours et de 20,5 jours, et l’amélioration moyenne à la GAF était de 14,8 et de 16,1, respectivement dans les 2 cas. La majorité des associations examinées
démontraient un degré élevé de signification avec des modèles semblables dans tous les contextes d’établissements généraux
et tertiaires. L’âge avancé et une réhospitalisation plus récente suivant un congé psychiatrique étaient associés à une DDS plus
longue et moins d’amélioration à la GAF. L’expérience récente d’événements de vie défavorables et l’abus de substances
étaient associés à une DDS plus courte.
Conclusions : Bien que les résultats de cette analyse transversale exploratoire demandent plus de recherche en ce qui
concerne la validité et la fiabilité, ils suggèrent qu’une trajectoire de service différente est probablement nécessaire pour les
personnes ayant un problème psychosocial plus grave et de lourds antécédents d’utilisation des services.
Keywords
schizophrenia, length of stay, inpatient, functioning

The challenges that have attended the development of effective treatment and service approaches for schizophrenia are
well documented, as are the extensive system costs attributed to the illness.1 Of these costs, inpatient care is the largest contributor in most jurisdictions,2-4 with schizophrenia
accounting for the longest lengths of stay (LOS).5 Correlates
of LOS in this population have included, along with illness
severity, a range of demographic, social, and economic factors.6,7 However, these findings have been inconsistent. For
example, male gender has variably been unassociated8 with
LOS and associated with longer4,9 and shorter LOS.10 Such
inconsistencies may partly be due to the methodological
limitations. Many studies have used small samples, not controlled for the effects of repeated admissions,8 and have not
considered hospital effects.4 This represents a problem at
system and policy development levels as care models for
schizophrenia are increasingly under scrutiny due to budgetary constraints and an emphasis upon community-based
care.11 Such planning needs to be informed by service utilisation data that are representative of Canadian contexts and
populations. Systematic data collection through the Ontario
Mental Health Reporting System (OMHRS) is the most comprehensive source of such information at a provincial level.
Using data from OMHRS, this article aims to examine the
association between patient characteristics and inpatient
LOS and functional improvement of schizophrenia and other
major psychotic illnesses. Attending to service utilisation
and outcome trends as a function of these variables could
allow for more informed mental health system and service
planning. This study is among the most comprehensive to
date internationally and the first such study undertaken with
Canadian data.

Methods
Data Source
Data for this study were obtained from the OMHRS. Implemented in October 2005, OMHRS contains information on
all hospital admissions for adults admitted to the approximately 5000 mental health beds in Ontario. OMHRS data are
derived from the Resident Assessment Instrument–Mental
Health (RAI-MH), which is a comprehensive, mandatory,
and standardised assessment tool for inpatient psychiatry and
includes information on patient demographics, socioeconomic status, diagnosis, substance use, psychiatric symptoms, cognition, and functioning.12,13 The reliability and
validity of the RAI-MH have been established in a number
of previous studies. Specific domains include acceptable to
high average interrater reliability based on kappa coefficients and percentage agreement between raters.13
OMHRS records, purchased from the Canadian Institute
for Health Information (CIHI), were obtained for all people
admitted and discharged between October 1, 2005, and June
30, 2015, from a psychiatric bed in Ontario based on the
OMHRS code for a primary diagnosis of schizophrenia
and/or other psychoses (based on DSM-IV diagnostic category, including schizophrenia, schizoaffective disorder,
schizophreniform disorder, delusional disorder, brief psychotic disorder, shared psychotic disorder, psychotic disorder due to medical conditions, substance-induced psychotic
disorder, and psychotic disorder not otherwise specified).
There is no specific category for ‘schizophrenia’ in isolation
in this database. Patients without completed RAI-MH data,
having a forensic status, or having an ‘unplanned discharge’
were excluded as confounds within the scope of this
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analysis. This study received approval from the Research
Ethics Board of the Centre for Addiction and Mental Health
(REB reference 093/2015).

Outcome Measures
Two outcome measures were included in this study: LOS (in
days) and the functional improvement for each patient, measured as the difference of Global Assessment of Functioning
(GAF) scores between discharge and admission. LOS is an
important performance indicator for costing and hospital
management and a key measure of efficiency of a health
care system.14 The LOS per episode was adjusted by excluding alternate level of care (ALC) days, which reflect systems
considerations outside of the control of hospitals (e.g., housing, adequate case management).15 GAF provides a global
rating of severity across psychiatric diagnoses. It is used
widely and captures psychiatric symptom severity and social
and occupational functioning.16 Scores range from 1 to 100,
with 100 representing an absence of symptoms and superior
functioning. While GAF has been found to be a reliable and
valid measure for examining patient outcome and program
performance, a shortcoming in this database is the possibility
of different intake-discharge raters17 and other concerns that
might account for its removal from the DSM-5.18

Patient Characteristic Variables
We extracted the following patient-level variables from the
OMHRS data set: sex, age, language spoken, marital status,
education level, employment, residential stability, number of
previous psychiatric admissions, time since last psychiatric
discharge, admission reasons, history of medication refusal,
adverse life event experience, substance use, alcohol, and
smoking.
For adverse life events, OMHRS has a variable for each
of the following 8 major adverse life events categorised by
recency: serious accident or physical impairment; death of a
close family member or friend; major loss of income or
serious economic hardship due to poverty; immigration,
including refugee status; witness to severe accident, disaster,
or act of terrorism; violence or abuse; victim of crime; sexual
assault/abuse; and physical assault/abuse. In this study, we
pooled major adverse life events into a single variable,
adverse life events, and considered as a binary occurrence.
The data set has a variable for the following 6 substances:
inhalants, hallucinogens, cocaine and crack, stimulants, opiates, and cannabis. We pooled the above substance use items
into a single variable, substance use, with coding rules the
same as coding adverse life events.
Data were also available on reasons for admissions. We
focused on 2 variables—specifically, threat/danger to harm
self or others and inability to care for self—which were
binary coded.

The Canadian Journal of Psychiatry 62(12)

Analysis
Data were analysed with SPSS (version 21; SPSS, Inc., an
IBM Company, Chicago, IL). Descriptive analyses were
conducted for all variables. To address the question of which
patient variables are associated with LOS and GAF change,
we employed generalised linear mixed models (GLMMs) to
estimate the association between patient characteristics and
LOS and GAF improvement. GLMM is a flexible statistical
approach for analysing nonnormal data when random effects
are present.19 In this study, patient characteristics were set as
independent variables, and possible hospital ‘block’ effects
(e.g., policies, care culture) were set as random effects and
controlled by the GLMM as hospital characteristics can
influence patient LOS and outcome.20 Estimated effects
were reported as estimated marginal means (EMMs) and
contrast estimates. The contrast estimate is the difference
of EMM to the reference level of the variables.21,22

Results
Descriptive Analysis
A total of 114,812 episodes were extracted from the data
provided by CIHI. In total, 24,657 episodes were excluded
from the study cohort due to forensic status or unplanned
discharges. Another 1862 episodes, which were excluded
due to missing GAF data either at admission or discharge,
resulted in a total of 88,239 episodes included in this study.
In total, 39,741 (45.0%) of 88,239 episodes were repeated
admissions. The mean number of admissions per patient was
2.04 (SD ¼ 1.99; median ¼ 1; range, 1 to 43). To eliminate
the weighted effects of patient characteristics from readmitted patients on outcome measures, 1 episode was randomly selected for each multiple-admission patient,
leaving 48,498 episodes for distinct patients from 18 psychiatric hospitals (12,343) and 57 general hospitals (36,155).
For the psychiatric hospital subset, the average LOS was
96.6 days (SD ¼ 205.1; median ¼ 42.0; range, 1 to 3234)
(Table 1), and the average GAF improvement at discharge
relative to admission was 14.8 (SD ¼ 16.1; median ¼ 15.0;
range, –90 to 85; note that negative values reflect a decline in
admission to discharge change in scores) (Table 2). For the
general hospital subset, the average LOS was 20.5 (SD ¼
25.4; median ¼ 15.0; range, 1 to 1632), and the average GAF
improvement was 16.1 (SD ¼ 19.1; median ¼ 19.0; range, –
81 to 90).

GLMM Analysis and Estimation Results
The distributions of LOS for both the psychiatric hospital
and the general hospital subsets were positively skewed
(skew ¼ 7.144 and 27.158 for psychiatric and general hospitals, respectively). With logarithmic transformation, the
skew for the transformed LOS was 0.395 for the psychiatric
subset and 0.438 for the general hospital subset. No significant skew was observed for GAF.
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92.8 (197.7)
102.4 (216.0)
83.3 (170.9)
97.4 (226.2)
113.6 (219.9)
57.6
81.2
106.2
129.7
57.6
102.9
96.8
114.2
105.4 (234.0)
85.9 (148.9)
72.3 (110.0)
64.3 (99.5)
60.7 (86.6)
56.9 (99.7)
109.9
87.5
77.6
64.6
47.1
40.4

7540
4803
4751
4063
3529
1836
4487
2524
3496
1836
4742
3453
2312
7878
3247
783
158
85
192
8779
791
510
890
774
599

(234.1)
(114.2)
(121.7)
(87.5)
(82.3)
(48.2)

(133.8)
(244.8)
(181.1)
(191.8)

(133.8)
(163.5)
(205.2)
(268.5)

96.6 (205.1)

12,343

M (SD)

45.0
51.0
47.0
36.0
24.0
22.0

42.0
44.0
39.0
36.0
24.5
31.0

26.0
41.0
46.0
55.0

26.0
37.0
49.0
55.0

38.0
39.0
49.0

40.0
43.0

42.0

Median

95% CI

CE

(F ¼ 2.138, P ¼ 0.144)
112.1
81.3-154.5
Ref.
117.9
85.5-162.8
5.8
(F ¼ 15.31, P < 0.001)
100.8
73.4-138.6
Ref.
114.9
83.7-157.7
14.1
127.7
93.1-175.2
26.9
(F ¼ 34.377, P < 0.001)
72.4
52.0-100.9
Ref.
99.2
73.3-134.3
26.8
120.9
89.3-163.8
48.5
137.8
102.2-185.8
65.4
(F ¼ 15.01, P < 0.001)
74.6
52.3-106.3
Ref.
117.6
84.9-162.8
43.0
115.6
83.3-160.4
41.0
131.5
94.8-182.4
56.9
(F ¼ 9.729, P < 0.001)
126.3
90.7-175.8
Ref.
99.9
71.4-139.8
–26.4
87.4
60.2-126.8
–38.9
82.4
48.1-141.1
–43.9
72.5
34.0-154.6
–53.8
82.8
47.8-143.3
–43.6
(F ¼ 20.037, P < 0.001)
128.9
94.4-177.8
Ref.
91.2
63.9-130.3
–37.7
83.8
57.1-122.9
–45.1
76.0
52.3-110.3
–52.9
59.4
38.8-90.7
–69.6
57.4
35.1-94.9
–71.5

M

<0.001***
<0.001***
<0.001***
<0.001***
<0.001***

<0.001***
<0.001***
0.025*
0.046*
0.031*
***

<0.001***
<0.001***
<0.001***
***

<0.001***
<0.001***
<0.001***
***

0.007**
<0.001***
***

0.157
***

P

GLMM: Estimated Marginal Means

1496
835
1931
2983
2828

22,080
10,258
2095
604
467
651

11,877
13,703
7425
3150

11,877
14,128
4906
5244

15,022
11,586
9547

20,265
15,890

36,155

n

CE, contrast estimate; CI, confidence interval; GLMM, generalized linear mixed model; LOS, length of stay; M, mean; NA, not applicable.
*P < 0.05. **P < 0.01. ***P < 0.001.

Entire sample
Gender
Male
Female
Age, y
<35
35-50
>50
No. of previous psychiatric admissions
None
1-3 times
4-5 times
6 or more
Time since last psychiatric discharge
NA
More than a year
31 days to 1 year
30 days or less
Adverse life events
No
More than 1 year ago
31 days to 1 year
8-30 days
4-7 days
In the last 3 days
Substance use
Never or more than 1 year ago
Within the last year
Within the last 3 months
Within the last month
Within the last 7 days
Within the last 3 days

n

LOS, d

Psychiatric Hospitals

(28.8)
(18.2)
(17.3)
(19.1)
(35.9)
(19.9)

(18.4)
(27.3)
(20.7)
(43.4)

(18.4)
(23.2)
(39.0)
(28.5)

26,082
19.3 (16.4)
19.7 (15.8)
19.6 (40.2)
17.6 (14.3)
17.0 (13.3)

20.6
20.2
19.5
21.4
21.3
19.5

19.3
21.0
20.8
21.7

19.3
20.5
21.9
21.6

19.2 (21.5)
19.7 (29.6)
23.3 (25.5)

19.6 (27.4)
21.6 (22.7)

20.5 (25.4)

M (SD)

15.0
15.0
15.0
16.0
15.0
15.0

15.0
15.0
15.0
15.0

15.0
15.0
16.0
15.0

15.0
15.0
17.0

15.0
16.0

15.0

Median

21.3 (26.6)
15.0
15.0
14.0
14.0
13.0

LOS, d

95% CI

CE

(F ¼ 54.2, P < 0.001)
18.0-21.1
Ref.
19.8-23.1
1.9
(F ¼ 78.8, P < 0.001)
19.1
17.7-20.6
Ref.
19.7
18.2-21.2
0.6
22.9
21.2-24.7
3.8
(F ¼ 23.8, P < 0.001)
19.0
17.5-20.6
Ref.
20.4
18.8-22.1
1.4
22.1
20.3-24.0
3.1
21.5
19.8-23.3
2.5
(F ¼ 22.2, P < 0.001)
19.0
17.6-20.6
Ref.
20.8
19.2-22.5
1.8
20.6
19.0-22.4
1.6
22.6
20.7-24.6
3.6
(F ¼ 2.771, P ¼ 0.017)
20.7
19.1-22.4
Ref.
20.1
18.6-21.8
–0.5
18.8
17.1-20.6
–1.9
21.0
18.7-23.7
0.4
20.7
18.1-23.6
0.0
19.3
17.1-21.9
–1.3
(F ¼ 28, P < 0.001)
15.0
21.3
19.8-23.0
19.0
17.2-21.0
–2.3
19.1
17.1-21.5
–2.2
19.4
17.7-21.3
–1.9
17.2
15.7-18.9
–4.1
16.7
15.2-18.4
–4.6
19.5
21.4

M

0.076
0.001**
0.708
0.996
0.782
***
Ref.
<0.001***
0.01
0.001**
<0.001***
<0.001***

<0.001***
<0.001***
<0.001***
*

<0.001***
<0.001***
<0.001***
***

0.047*
<0.001***
***

<0.001***
***

***

P

GLMM: Estimated Marginal Means

General Hospitals (Psychiatric Beds)

Table 1. Factors Associated with LOS in Patients with Schizophrenia in Ontario Psychiatric Hospitals: Descriptive Statistics and GLMM Analysis.
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M (SD)

15.0
11.0
13.5
15.0
15.0
15.0

15.0
10.0

10.0
15.0
15.0
15.0

15.0
15.0
14.0
15.0

15.0
15.0
13.0
12.0

15.0
15.0
13.0

15.0
15.0

15.0

Median

95% CI

CE

(F ¼ 3.131, P ¼ 0.077)
12.5
9.7-15.3 Ref.
13.0 10.1-15.8
0.5
(F ¼ 5.875, P ¼ 0.003)
13.3
9.3-15.0 Ref.
12.6
9.7-15.4 –0.7
12.2 10.5-16.1 –1.2
(F ¼ 6.184, P < 0.001)
13.7 10.8-16.5 Ref.
13.3 10.4-16.0 –0.4
12.1
9.2-14.8 –1.6
12.2
9.4-15.0 –1.4
(F ¼ 3.078, P ¼ 0.026)
13.5 10.6-16.4 Ref.
12.5
9.7-15.3 –1.0
12.3
9.4-15.0 –1.3
13.0 10.1-15.8 –0.5
(F ¼ 22.09, P < 0.001)
10.5
7.6-13.3 Ref.
13.3 10.4-16.1
2.8
12.6
9.7-15.4
2.1
13.8 10.9-16.6
3.3
(F ¼ 11.192, P ¼ 0.001)
12.9 10.0-15.7 Ref.
11.3
8.2-14.2 –1.6
(F ¼ 2.476, P ¼ 0.03)
12.7
9.8-15.4 Ref.
12.3
9.2-15.2 –0.4
11.6
8.5-14.6 –1.0
13.5 10.5-16.4
0.9
13.0 10.0-16.0
0.4
14.1 11.0-17.1
1.4

M

0.495
0.147
0.107
0.504
0.032*

0.001**
*

M (SD)

11,877
13,703
7425
3150

11,877
14,128
4906
5244

(19.9)
(18.9)
(18.6)
(19.0)

(19.9)
(18.8)
(18.5)
(19.0)

(19.9)
(19.2)
(18.4)
(17.6)

26,082
1496
835
1931
2983
2828

16.1
16.2
17.0
16.1
16.9
14.6

(18.8)
(19.2)
(18.5)
(19.8)
(20.0)
(20.8)

31,614 16.5 (19.1)
3910 13.9 (17.6)

13.7
15.0
16.7
18.2

16.7
16.1
15.3
15.4

16.7
16.3
15.5
14.5

15,022 16.2 (19.8)
11,586 15.8 (19.1)
9547 16.1 (18.2)

20,265 15.6 (19.3)
15,890 16.6 (18.8)

19.0
20.0
20.0
20.0
20.0
15.0

20.0
15.0

15.0
15.0
20.0
20.0

20.0
19.0
15.0
15.0

20.0
20.0
15.0
15.0

20.0
18.0
16.0

17.0
20.0

19.0

Median

GAF Improvement

36,155 16.1 (19.1)

n

7686
<0.001*** 9084
<0.001*** 8802
<0.001*** 10,583

0.022*
0.006**
0.349
***

0.348
0.001**
0.002**

0.024*
0.001**
***

0.077

P

GLMM: Estimated Marginal Means

95% CI

CE
(F ¼ 14.7, P < 0.001)
15.2 13.0-17.4 Ref.
15.9 13.7-18.1 0.7
(F ¼ 0.726, P ¼ 0.484)
15.6 13.5-17.8 Ref.
15.4 13.2-17.6 –0.2
15.5 13.3-17.7 –0.1
(F ¼ 11.3, P < 0.001)
15.9 13.7-18.1 Ref.
15.8 13.6-18.0 –0.1
15.1 12.9-17.3 –0.8
14.3 12.1-16.5 –1.6
(F ¼ 3.7, P ¼ 0.011)
15.9 13.7-18.1 Ref.
15.5 13.4-17.7 –0.3
15.1 12.9-17.3 –0.8
15.1 12.8-17.3 –0.8
(F ¼ 38.1, P < 0.001)
14.0 11.8-16.2 Ref.
15.0 12.9-17.2 1
15.9 13.7-18.1 1.9
16.9 14.7-19.0 2.9
(F ¼ 21.1, P < 0.001)
15.9 13.7-18.1 Ref.
14.5 12.3-16.8 –1.4
(F ¼ 0.7, P ¼ 0.629)
15.5 13.3-17.7 Ref.
15.9 13.5-18.2 0.4
16.2 13.7-18.7 0.7
15.6 13.3-17.9 0.1
15.6 13.4-17.9 0.1
15.1 12.9-17.4 –0.4

M

0.388
0.253
0.722
0.681
0.326

<0.001***

<0.001***
<0.001***
<0.001***
***

0.138
0.003**
0.022*
***

0.687
<0.001***
<0.001***

0.242
0.455
***

<0.001***

***

P

GLMM: Estimated Marginal Means

General Hospitals (Psychiatric Beds)

CE, contrast estimate; CI, confidence interval; GAF, Global Assessment of Functioning; GLMM, generalized linear mixed model; LOS, length of stay; M, mean; NA, not applicable.
*P < 0.05. **P < 0.01. ***P < 0.001.

Entire sample
12,343 14.8 (16.1)
Gender
Male
7540 14.6 (16.1)
Female
4803 15.2 (16.0)
Age, y
<35
4751 15.5 (15.8)
35-50
4063 14.5 (16.4)
>50
3529 14.2 (16.0)
No. of previous psychiatric admissions
None
1836 16.1 (18.2)
1-3 times
4487 15.4 (15.5)
4-5 times
2524 13.9 (15.9)
6 or more
3496 13.9 (15.7)
Time since last psychiatric discharge
NA
1836 16.1 (18.2)
More than a year
4742 14.8 (15.8)
31 days to 1 year
3453 14.0 (15.7)
30 days or less
2312 14.9 (15.3)
Admission reasons: threat/danger to harm self or others, inability to care self
None of the above (but other reasons)
2236 12.34 (15.9)
Threat/danger to harm self or others
2481 15.1 (16.7)
Inability to care self
3790 14.7 (15.2)
All of the above reasons
3836 16.1 (16.4)
Medication refusal
No
11,110 15.1 (16.1)
Yes
1152 12.9 (14.7)
Substance use
Never or more than 1 year ago
8779 14.7 (16.0)
Within the last year
791 13.5 (15.4)
Within the last 3 months
510 13.3 (15.9)
Within the last month
890 15.6 (15.6)
Within the last 7 days
774 15.4 (18.6)
Within the last 3 days
599 16.5 (15.2)

n

GAF Improvement

Psychiatric Hospitals

Table 2. Factors Associated with GAF Improvement for Schizophrenia Inpatient Stay in Ontario Psychiatric Hospitals: Descriptive Statistics and GLMM Analysis.
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Table 3. Summary of the Association between Patient Characteristic Factors and LOS and GAF Improvement.
Significance of the Associations
LOS
Factors
Static demographic
Gender
Age
Language spoken
Psychosocial
Marital status
Education level
Employment
Residential stability
Services
Number of previous psychiatric
admissions
Time since last psychiatric discharge
Admission reasons
History of medication refusal
Challenges
Adverse life events
Substance
Alcohol
Smoking

GAF Improvement

Significance

Data Set

Significance

Data Set

***(Female ¼ þLOS)
***(Older patients ¼ þLOS)
***(French speaking ¼ þLOS)

2
1 and 2
1

***(Female ¼ þGAF)
**(Older patients ¼ –GAF)

2
1

***(Married/partner ¼ –LOS)
***(Higher education ¼ –LOS)
***(Employment ¼ –LOS)

1 and 2
1
1 and 2

***(Married/partner ¼ þGAF)
**(Higher education ¼ þGAF)
***(Employment ¼ þGAF)

2
1 and 2
1 and 2

***(More previous admissions ¼
þLOS)
***(Shorter time ¼ þLOS)
***(Inability to care self ¼ þLOS)

1 and 2

***(More previous admissions ¼
–GAF)
*(No apparent association direction)
***(With studied reasons ¼ þGAF)
**(History of medication refusal ¼
– GAF)

1 and 2

***(Recent adverse life events ¼
–LOS)
***(Recent substance use ¼ –LOS)
***(Recent alcohol consumption ¼
–LOS)
***(Smoking ¼ –LOS)

1
1 and 2
1 and 2

*(Recent substance use ¼ þGAF)

1

1 and 2

***(Recent smoking ¼ –GAF)

1 and 2

1 and 2
1 and 2

1 and 2
1 and 2

Data set 1 ¼ psychiatric hospital subset; data set 2 ¼ general hospital subset. GAF, Global Assessment of Functioning; LOS, length of stay.
*P < 0.05. **P < 0.01. ***P < 0.001.

Patient characteristic variables were clustered into 4
groups: demographic factors, psychosocial factors, service
factors, and challenges. Table 3 summarises the major findings of the study.

Static Demographic Factors
We did not observe a significant association between patient
sex and either LOS or GAF improvement for episodes in
psychiatric hospitals (Tables 1 and 2). For general hospital
episodes, there was a significant association for sex on both
LOS and GAF improvement, with female patients being
estimated (contrast estimate or CE) to stay 1.9 days longer
and gain 0.7 more GAF points.
Age was significantly associated with LOS for episodes
from both the psychiatric hospitals and general hospitals,
with patients older than 50 years staying an average of
26.9 days longer in psychiatric hospitals and 3.8 days longer
in general hospitals (Table 1). While not significant for general hospitals, in psychiatric hospitals, patients older than 50
years had 1.2 points less gain on the GAF (Table 2).
Language spoken was a significant contributor to LOS for
psychiatric hospital episodes, with French-speaking patients
estimated to have an LOS 65.9 days longer than Englishspeaking patients, although sample size was an issue in this
analysis (Suppl. Table S1).

Psychosocial Factors
Patients who were married or had a partner were estimated to
have a shorter LOS by 27.6 days (psychiatric) and 1.6 days
(general) (Supplemental Table S1) and, in general hospitals,
gain 1.1 points more on the GAF (Supplemental Table S2).
Patients with an education level of high school or above
were estimated to have a shorter LOS by 29.2 days (psychiatric) and 0.6 days (general) (Suppl. Table S1) and gained 0.9
more points on the GAF in both psychiatric and general
hospitals (Suppl. Table S2). Patients who were employed
were estimated to stay 58.1 days (psychiatric) or 4.6 days
(general) less (Suppl. Table S1) and gain 2.1 points (psychiatric) and 1.2 points (general) more on the GAF (Suppl.
Table S2).

Service Use
Greater numbers of previous psychiatric admissions were
associated with longer LOS (Table 1, Figure 1) and fewer
gains on GAF in both hospital types (Table 2). Recency of
readmission following a psychiatric discharge was associated with longer LOS (Table 1 and Figure 1) and less GAF
improvement (Table 2). Patients who had a psychiatric
discharge within 30 days were estimated to stay 56.9 days
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p
General Hospitals

140
120
100
80
60
40
20
0

A1
LOS (d)

LOS (d)

Psychiatric Hospitals
23
22
21
20
19
18
17
16

A2

140
120
100
80
60
40
20
0

23

B1

B2

22

LOS (d)

LOS (d)

Previous psychiatric admissions

21
20
19
18
17
16

140
120
100
80
60
40
20
0

C1

23

C2

22

LOS (d)

LOS (d)

Time since last psychiatric discharge

21
20
19
18
17
16

Adverse life events
140
120

D1

23

100

21

80

LOS (d)

LOS (d)

D2

22

60
40

20
19
18

20

17

0

16

Substance use
Figure 1. The impact of selected factors on observed and Global Assessment of Functioning (GLMM) estimated marginal mean length of
stay (LOS).
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(psychiatric) or 3.6 days (general) longer (Table 1 and
Figure 1).
Patients who were admitted because they demonstrated a
threat/danger to harm self/others and inability to care for self
were estimated to stay 43.7 days (psychiatric) or 3.4 days
(general) longer (Suppl. Table S1) and gain 3.3 points (psychiatric) or 2.9 points (general) more in GAF scores (Table
2). Medication refusal while in hospital did not have a significant impact on LOS (Suppl. Table S1) but was associated
with less changes in GAF in both psychiatric hospitals (1.6
points) and general hospitals (1.4 points) (Table 2).

Challenges
The more recently that patients experienced adverse life
events, the shorter the LOS (Table 1 and Figure 1). Adverse
life events were not associated with GAF change. With
respect to substance use, the more recent the reported use,
the shorter the LOS for both hospital types (Table 1 and
Figure 1), and for psychiatric hospitals, those who used substances ‘within the last 3 days’ were estimated to gain 1.4
more GAF points than those who denied use in the past year
(Table 2).
Alcohol consumption at any time in the 14 days prior to
current admission was significantly associated with shorter
LOS in both hospital types, with those reporting 5 or more
drinks per sitting estimated to stay 49.5 days (psychiatric) or
4.0 days (general) less (Suppl. Table S1). No association
with GAF was noted (Suppl. Table S2). Smoking was significantly associated with both LOS and GAF measures.
Patients who smoked in the last 3 days prior to admission
had lower LOS by 19.0 days (psychiatric) and 3.7 days (general) (Suppl. Table S1). Associations with GAF scores were
less consistent (Suppl. Table S2).

Discussion
This article was intended to provide a descriptive profile of
hospitalisation of individuals with schizophrenia and other
psychotic disorders using a large provincial database. These
findings indicated a median LOS that is longer (42 days for
psychiatric hospitals and 15 for general hospitals) than previously reported national CIHI data from 2009 to 2010 (35
days for psychiatric hospitals and 13 days general hospitals),
although a lower mean LOS (96.6 vs. 144.6 days for psychiatric hospitals and 20.5 vs. 23.4 days for general hospitals).5 However, the meaning of these differences is difficult
to interpret and, while possibly having implications regarding service utilisation (e.g., fewer very long stay patients
hospitalised in Ontario), they could readily be a product of
methodology. Key considerations include diagnostic parameters and how forensic patients, multiple admissions, and
incomplete data were addressed, which might account for
the differences observed. Both current and CIHI national
data sets note markedly higher LOS among schizophrenia
and psychosis populations compared with mean LOS

861

findings across all mental illness and addictions diagnoses
(CIHI mean of 80.5 days psychiatric; 18.3 days general).5
More broadly, the results of the present study are comparable
with findings in the United Kingdom (47.7 days, schizophrenia; 41.1 days, schizoaffective and other psychoses).8 This
observation might be a function of similar health care systems as the observed length of stay in Korea was found to be
much longer for schizophrenia (217 days).4
Comparative data are more difficult to generate regarding
GAF improvement (mean of 14.8 points for psychiatric hospitals and 16.1 for general), but such a degree of improvement would seem modest given that crises typically prompt
hospitalisation, the intensity of inpatient services, and
lengthy LOS. Consistent with Jacobs et al.,8 for psychiatric
hospitals, we did not observe a significant difference in LOS
as a function of sex or GAF change. While, for psychiatric
hospitals, this is suggestive of a lack of systemic difference
in care as a function of sex, the longer lengths of stay with
greater improvement for females in general hospitals are
more difficult to interpret. The association between age,
LOS, and GAF change matches what might be expected
given the care complexities that attend aging and align with
previous work in this area.23 The finding of markedly longer
LOS among French-speaking patients in psychiatric hospitals bears further analysis, although it aligns with previous
research, which found that French-speaking patients were
about one-third as likely to have daily contact with a psychiatrist in the first 3 days of admission.24
The associations observed between psychosocial factors, LOS, and GAF improvement are consistent with other
research on psychosocial determinants, suggesting better
trajectories among individuals with greater social support
(e.g., married) and better engagement with education and
employment.25,26
As proxy indicators of acuity, with implications for the
adequacy of supports postdischarge,27 the number of previous hospitalisations and recency of prior discharge suggest a
pattern of individuals with more hospitalisations and more
difficult community transitions having long LOS and making fewer gains. The finding that threat of harm and inability
to care for self were associated with longer LOS would seem
intuitive, and greater GAF change for such individuals might
have occurred as a function of admission while in acute crisis
and the range of potential gain being greater. Lastly, with
respect to service-oriented indicators, the observation of
medication refusal being associated with less gain could
possibly be an indication of a subset of patients who are less
engaged in care generally.28,29
With respect to challenges, a picture emerged of the
recency of adverse life events being linked with LOS in a
linear fashion—an association that mirrors recent life
adversity-psychosis severity findings.30 This potentially
suggests that acuity driven by environmental adversity
might more readily be addressed in a shorter period than
acuity driven by other factors (e.g., more biologically
determined).
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Similarly, with adverse life events, and consistent with
previous literature,8,31,32 we found that shorter LOS was
associated with substance or alcohol misuse. This finding
might suggest that they, as determinants of acuity, are more
readily resolved in hospital following inpatient detoxification. Furthermore, such patients may be more likely to leave
against medical advice (self-discharge) and are motivated to
show improvement so they can leave to regain access to
drugs or alcohol. Similarly, the association between smoking
and lower LOS might indicate greater motivation to be discharged in contexts where access to tobacco is difficult.
With respect to implications, these findings support the
utility of approaches such as assertive community treatment
and intensive case management that focus on those demonstrating very difficult transitions to community and limited
gains in hospital.33,34 Also supported are implications for
greater gains in shorter periods and interventions that might
enhance such gains, in scenarios in which acuity is driven to
a greater extent by environmental stressors and/or addictions. More broadly, systematic approaches are needed, such
as integrated care pathways,35 as it is clear that there are
diverse service utilisation patterns that are predictable and
likely require quite different approaches within the same
diagnostic category. Initiatives to set standards for inpatient
schizophrenia care such as those recently released by Health
Quality Ontario are an important step in this direction.36
Finally, it would be helpful from an equity perspective if
race and ethnicity could be integrated into mandatory data
collection given that this study indicated systematic differences as a function of language and sex.

Limitations
Limitations include the cross-sectional nature of the analysis, the use of data from a single Canadian province, complexities that attend transfers of patients from general to
tertiary facilities, and the challenges that attend some of the
metrics employed in clinical practice (e.g., GAF ratings).
Additionally, the OMHRS does not have a specific variable
for schizophrenia, which introduces variability attending
other psychotic illnesses with diverse presentations and care
trajectories, and it does not capture all the relevant parameters contributing to LOS, such as community services and
social and family supports, which have dramatic impact on
LOS.37,38 Similarly, the OMHRS does not capture emergency room days, which might have resulted in lower LOS
findings. Lastly, it would be beneficial if future analyses
unpacked the possible differential impacts of individual
types of adversity that preceded hospitalisation and considerations such as substance use type.
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